Collectively, these findings unveil the post-transcriptional and transcriptional mechanism and functional importance of YBX1 in autophagy and adipogenesis regulation, providing an attractive molecular target for therapies of obesity and metabolic diseases. The gene discussed is YBX1; the disease is obesity due to melanocortin 4 receptor deficiency.